UAMS’ Peter Emanuel, M.D., Appointed to Association of American Cancer Institutes Board of Directors

By Susan Van Dusen

Peter Emanuel, M.D.

Peter Emanuel, M.D.

Emanuel will serve a two-year term after being appointed to fill a vacated seat on the board.

Emanuel’s translational research interests have focused for more than 25 years on myeloproliferative neoplasms, and his laboratory is an international leader in investigating juvenile myelomonocytic leukemia. He has served as director of the UAMS Cancer Institute since 2007.

AACI comprises 94 premier academic and freestanding cancer research centers in the United States. It is dedicated to reducing the burden of cancer by enhancing the impact of the nation’s leading academic cancer centers.

UAMS is the state's only health sciences university, with colleges of Medicine, Nursing, Pharmacy, Health Professions and Public Health; a graduate school; a hospital; a main campus in Little Rock; a Northwest Arkansas regional campus in Fayetteville; a statewide network of regional campuses; and seven institutes: the Winthrop P. Rockefeller Cancer Institute, Jackson T. Stephens Spine & Neurosciences Institute, Harvey & Bernice Jones Eye Institute, Psychiatric Research Institute, Donald W. Reynolds Institute on Aging, Translational Research Institute and Institute for Digital Health & Innovation. UAMS includes UAMS Health, a statewide health system that encompasses all of UAMS' clinical enterprise. UAMS is the only adult Level 1 trauma center in the state. UAMS has 3,275 students, 890 medical residents and fellows, and five dental residents. It is the state's largest public employer with more than 12,000 employees, including 1,200 physicians who provide care to patients at UAMS, its regional campuses, Arkansas Children's, the VA Medical Center and Baptist Health. Visit or Find us on Facebook, X (formerly Twitter), YouTube or Instagram.